A potential limitation of this study is that approximately half of REAL3 tumours had tissue available for amplification testing as many samples were used in previous biomarker studies.36 37 Specifically, small numbers of EGFR-amplified cases were included in the survival analyses limiting the power of this work. This evidence concerns the gene EGFR and neoplasm.